Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hilton Hotels Corporation Common Stock (HLT) vs Eli Lilly And Co (LLY) Price & Performance

Hilton Hotels Corporation Common StockTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Hilton Hotels Corporation Common Stock vs Eli Lilly And Co — how do they compare? Hilton Hotels Corporation Common Stock trades at $318 (market cap $70.82B), while Eli Lilly And Co trades at $1,211 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 15.2× Hilton Hotels Corporation Common Stock's market cap, and Eli Lilly And Co pays the higher dividend (0.57%). Which is the better fit depends on your goals.

HLTLLY
Market Cap
$70.82B$1.08T
Sector
Consumer CyclicalHealth
52-Week High
$350.22$1.24K
52-Week Low
$256.75$639.43
Enterprise Value
$83.83B$1.13T
Dividend Yield
0.19%0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hilton Hotels Corporation Common Stock

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hilton Hotels Corporation Common Stock

Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.

Read more on HLT

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY